Some of them include: L-carnitine may also enhance heart function in patients with severe heart disorders, including chronic heart failure
On one end are clinicians who treat eating disorders that see restrictive eating in any form [a]s pathological. They may refuse to prescribe GLP-1s to patients with even a distant history of disordered eating
For context, in a major semaglutide weight loss study using the 2.4 mg dose (marketed as Wegovy for weight management), average weight loss at 12 weeks was about 9.6% of starting body weight
Data are available to request 6 months after the indication studied has been approved in the United States and the European Union and after primary publication acceptance, whichever is later
see Methods for more detail) 25,26
Losses from medical bills, decreased earning potential and many other problems can pile up unexpectedly